TPG, a global alternative asset firm, today announced the final close of its latest Asian focused private equity fund, TPG Capital Asia VII. The fund raised over $4.6 billion in commitments, exceeding the fund’s target.

photo-1523958203904-cdcb402031fd

Image: TPG closes Asia VII with over $4.6bn of commitments. Photo: courtesy of rawpixel/Unsplash.com.

“Thanks to the continued support of our global investor  partners, we surpassed the target figure for TPG Asia VII. We are proud to have  reached this milestone,” said Ganen Sarvananthan, Co-Managing Partner for TPG  Capital Asia. “With Asia VII, we will continue to invest in opportunities that  reflect our differentiated investment strategy, deep sector expertise, and  focus on operational improvement. We look forward to continuing to deliver  value for our investors while helping to build great new companies across  Asia.”

“We are incredibly grateful for the trust placed in  us by both our long-standing partners, many of whom have invested with us over  multiple funds, and welcome a new group of limited partners to Asia VII,” said  Stephen Bamford, Partner and Co-Head of Fundraising at TPG said.

TPG Asia VII has so far committed more than 40 percent of  the capital across 12 companies, including, Du Xiaoman, the consumer lending,  wealth management and payments platform spun out from Baidu; Pathology Asia  Holdings, Healthscope’s Asian Pathology business that operates 39 labs across  Singapore, Malaysia and Vietnam; UPL, a global leader in agricultural  solutions; and Greencross Limited, an ASX-listed integrated pet care platform  in Australia.

2019 marks TPG’s 25th year investing in Asia, since establishing  its first regionally-dedicated fund in 1994. Comprised of approximately 50  investment professionals, the TPG Capital Asia team is based in TPG’s offices  in Beijing, Hong Kong, Mumbai, Seoul, Singapore, and Melbourne. The platform  has invested $11 billion in 88 investments across 13 countries through varied  local and regional economic cycles. The team pursues investments in a broad  range of industries, with a significant focus on financial services,  healthcare, consumer, and TMT/new economy.

Source: Company Press Release